{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:44:35Z","timestamp":1790804675962,"version":"4.1.0"},"reference-count":111,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2011,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title\/>\n            <jats:p>Approximately 400 million worldwide are chronically infected with the hepatitis B virus (HBV). During the course of illness, approximately 20% of patients develop disease manifestations outside the liver. Neuropathy develops in approximately 5% of patients with chronic HBV infection and rarely during acute HBV infection. The pathogenesis of the various HBV-associated neuropathy syndromes possibly involves deposition of immune complexes in nerves or blood vessel walls. Direct viral infection of nerves has not been demonstrated. Management entailed supportive care with antiviral and immunomodulatory treatment as clinically indicated. Rare cases of muscle disease, mostly inflammatory myopathy, have been associated with HBV infection. Presumably, HBV-associated antigens trigger immune mechanisms directed against components of muscle tissue. There is no evidence of replicative virus infection of muscle fibers. Management entailed immunomodulatory treatment, occasionally with anti-HBV therapy. Physicians should be aware that HBV infection has the potential to trigger presumed immune-mediated neuromuscular syndromes.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/cnd.0b013e3181df2b2b","type":"journal-article","created":{"date-parts":[[2011,10,4]],"date-time":"2011-10-04T19:51:21Z","timestamp":1317757881000},"page":"26-37","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":25,"title":["Neuromuscular Disorders Associated With Hepatitis B Virus Infection"],"prefix":"10.1097","volume":"13","author":[{"given":"Joerg-Patrick","family":"St\u00fcbgen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-3-20240808","first-page":"1","article-title":"Protection against viral hepatitis. Recommendations of the immunization practices advisory committee.","volume":"39","year":"1990","journal-title":"MMWR"},{"issue":"Suppl","key":"R2-3-20240808","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1002\/hep.22881","article-title":"Hepatitis B: the virus and disease.","volume":"49","author":"Liang","year":"2009","journal-title":"Hepatology"},{"key":"R3-3-20240808","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1016\/S0140-6736(03)15108-2","article-title":"Viral hepatitis B.","volume":"362","author":"Lai","year":"2003","journal-title":"Lancet"},{"key":"R4-3-20240808","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1056\/NEJM199712113372406","article-title":"Hepatitis B virus infection.","volume":"337","author":"Lee","year":"1997","journal-title":"N Eng J Med"},{"key":"R5-3-20240808","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1053\/jhep.2001.29401","article-title":"Chronic hepatitis B.","volume":"34","author":"Lok","year":"2001","journal-title":"Hepatology"},{"key":"R6-3-20240808","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1053\/jhep.2003.50453","article-title":"Exploring the biological basis of hepatitis B e antigen in hepatitis B virus infection.","volume":"38","author":"Milich","year":"2003","journal-title":"Hepatology"},{"key":"R7-3-20240808","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.rdc.2009.03.006","article-title":"Hepatitis B-related autoimmune manifestations.","volume":"35","author":"Cacoub","year":"2009","journal-title":"Rheum Dis Clin N Am"},{"key":"R8-3-20240808","first-page":"53","article-title":"Role of viral replication in extrahepatic syndromes related to hepatitis B virus infection.","volume":"52","author":"Mason","year":"2006","journal-title":"Minerva Gastroenterol Dietol"},{"key":"R9-3-20240808","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.jhep.2005.05.029","article-title":"Hepatitis B virus genotypes and extrahepatic manifestations.","volume":"43","author":"Cacoub","year":"2005","journal-title":"J Hepatol"},{"key":"R10-3-20240808","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s11894-001-0044-1","article-title":"Extrahepatic manifestations of chronic viral hepatitis.","volume":"3","author":"Pyrsopoulos","year":"2001","journal-title":"Curr Gastroenterol Rep"},{"key":"R11-3-20240808","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.gtc.2004.04.013","article-title":"Antiviral therapy: a role in the management of extrahepatic diseases.","volume":"33","author":"Kim","year":"2004","journal-title":"Gastroenterol Clin N Am"},{"key":"R12-3-20240808","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.cld.2004.02.003","article-title":"Extrahepatic manifestations of chronic hepatitis B.","volume":"8","author":"Han","year":"2004","journal-title":"Clin Liver Dis"},{"key":"R13-3-20240808","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s12016-007-8013-6","article-title":"Hepatitis B virus (HBV) and autoimmune disease.","volume":"34","author":"Maya","year":"2008","journal-title":"Clin Rev Allergy Immunol"},{"key":"R14-3-20240808","first-page":"3","article-title":"Extrahepatic manifestations of chronic viral hepatitis.","volume":"92","author":"Wilson","year":"1997","journal-title":"Am J Gastroenterol"},{"key":"R15-3-20240808","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0016-5085(95)90020-9","article-title":"Immunologic features and HLA associations in chronic viral hepatitis.","volume":"108","author":"Czaja","year":"1995","journal-title":"Gastroenterology"},{"key":"R16-3-20240808","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/hep.510240309","article-title":"Autoantibody prevalence in chronic hepatitis B virus infection: effect of interferon alfa.","volume":"24","author":"Gregorio","year":"1996","journal-title":"Hepatology"},{"key":"R17-3-20240808","first-page":"12","article-title":"Correlation of autoimmune reactivity with hepatitis B and C virus (HBV and HCV) infection in histologically proven chronic liver disease.","volume":"20","author":"Shantha","year":"2001","journal-title":"Indian J Med Microbiol"},{"key":"R18-3-20240808","first-page":"353","article-title":"Immune status and autoantibody formation in children with chronic hepatitis B infection.","volume":"44","author":"Unal","year":"2002","journal-title":"Panminerva Med"},{"key":"R19-3-20240808","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1097\/01.meg.0000059140.68845.74","article-title":"Anticardiolipin antibodies in chronic hepatitis B and chronic hepatitis infection, and hepatitis B-related hepatocellular carcinoma. Relationship with portal vein thrombosis.","volume":"15","author":"Elefsiniotis","year":"2003","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R20-3-20240808","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1042\/cs0680123","article-title":"Liver-specific autoantibodies in chronic hepatitis B virus infection.","volume":"68","author":"Meliconi","year":"1985","journal-title":"Clin Sci (Lond)"},{"key":"R21-3-20240808","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1365-2249.2006.03046.x","article-title":"Anti-PCNA autoantibodies preferentially recognize C-terminal of PCNA in patients with chronic hepatitis B virus infection.","volume":"144","author":"Hsu","year":"2006","journal-title":"Clin Exp Immunol"},{"key":"R22-3-20240808","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1136\/ard.58.10.630","article-title":"Presentation of autoantibody to proliferating cell nuclear antigen in patients with chronic hepatitis B and C virus infection.","volume":"58","author":"Tzang","year":"1999","journal-title":"Ann Rheum Dis"},{"key":"R23-3-20240808","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1056\/NEJM197706302962605","article-title":"Association between hepatitis B virus and essential mixed cryoglobulinemia.","volume":"296","author":"Levo","year":"1977","journal-title":"N Engl J Med"},{"key":"R24-3-20240808","doi-asserted-by":"crossref","first-page":"379","DOI":"10.7326\/0003-4819-92-3-379","article-title":"Essential mixed cryoglobulinemia without evidence for hepatitis B virus infection.","volume":"92","author":"Popp","year":"1980","journal-title":"Ann Intern Med"},{"key":"R25-3-20240808","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/0016-5085(94)90022-1","article-title":"Cryoglobulinemia in chronic liver disease: role of hepatitis C virus and liver damage.","volume":"106","author":"Lunel","year":"1994","journal-title":"Gastroenterology"},{"key":"R26-3-20240808","first-page":"209","article-title":"Hepatitis B virus-related markers in secondary and essential mixed cryoglobulinemias: a multicentric study of 596 cases. The Italian Group for the Study of Cryoglobulinemias (GISC).","volume":"7","author":"Galli","year":"1992","journal-title":"Ann Ital Med Int"},{"key":"R27-3-20240808","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1111\/j.1572-0241.2005.41308.x","article-title":"Hepatitis B virus replication in damaged endothelial tissues of patients with extrahepatic disease.","volume":"100","author":"Mason","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"R28-3-20240808","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s004670050417","article-title":"In situ hybridization of hepatitis B DNA in hepatitis B-associated glomerulonephritis.","volume":"12","author":"He","year":"1998","journal-title":"Pediatr Nephrol"},{"key":"R29-3-20240808","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1159\/000199217","article-title":"Mononeuritis in acute viral hepatitis.","volume":"32","author":"Pelletier","year":"1985","journal-title":"Digestion"},{"key":"R31-3-20240808","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1136\/ard.60.2.170","article-title":"Geoepidemiology of systemic vasculitis: comparison of the incidence in two regions of Europe.","volume":"60","author":"Watts","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"R32-3-20240808","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0140-6736(70)90339-9","article-title":"Association between polyarteritis and Australia antigen.","volume":"2","author":"Gocke","year":"1970","journal-title":"Lancet"},{"key":"R33-3-20240808","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/00005792-199509000-00002","article-title":"Polyarteritis nodosa related to hepatitis B virus. A prospective study with long-term observation of 41 patients.","volume":"74","author":"Guillevin","year":"1995","journal-title":"Medicine (Baltimore)"},{"key":"R34-3-20240808","first-page":"1575","article-title":"Antigene Australia, hepatite a virus et periarterite noueuse.","volume":"78","author":"Trepo","year":"1970","journal-title":"Presse Med"},{"key":"R35-3-20240808","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005792-197601000-00001","article-title":"Vasculitis with hepatitis B antigenemia: long-term observations in nine patients.","volume":"55","author":"Sergent","year":"1976","journal-title":"Medicine"},{"key":"R37-3-20240808","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1024\/0040-5930.65.5.247","article-title":"Polyarteritis nodosa, a vanishing vasculitis since its main cause has been identified.","volume":"65","author":"Frey","year":"2008","journal-title":"Ther Umsch"},{"key":"R38-3-20240808","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/01.md.0000180792.80212.5e","article-title":"Hepatitis B virus-associated polyarteritis nodosa: clinical characteristics, outcome, and impact of treatment in 115 patients.","volume":"84","author":"Guillevin","year":"2005","journal-title":"Medicine (Baltimore)"},{"key":"R39-3-20240808","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1055\/s-2008-1040426","article-title":"Serologic diagnosis of acute and chronic viral hepatitis.","volume":"11","author":"Hoofnagle","year":"1991","journal-title":"Semin Liver Dis"},{"key":"R40-3-20240808","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/0002-9343(80)90170-9","article-title":"Hepatitis B antigen-associated periarteritis nodosa in patients undergoing long-term hemodialysis.","volume":"68","author":"Drueke","year":"1980","journal-title":"Am J Med"},{"key":"R41-3-20240808","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/0002-9343(67)90144-1","article-title":"Long-term follow-up study of periarteritis nodosa.","volume":"43","author":"Frohnert","year":"1967","journal-title":"Am J Med"},{"key":"R42-3-20240808","first-page":"405","article-title":"Treatment of polyarteritis nodosa and Churg-Straus syndrome. A meta-analysis of 3 prospective controlled trials including 182 patients over 12 years.","volume":"143","author":"Guillevin","year":"1992","journal-title":"Ann Med Interne"},{"key":"R43-3-20240808","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1093\/rheumatology\/27.4.258","article-title":"Clinical findings and prognosis of polyarteritis nodosa and Churg-Strauss angiitis: a study of 165 patients.","volume":"27","author":"Guillevin","year":"1988","journal-title":"Br J Rheumatol"},{"key":"R44-3-20240808","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S0022-5347(17)38686-X","article-title":"Symptomatic urogenital manifestations of polyarteritis nodosa and Churg-Strauss angiitis.","volume":"142","author":"Azar","year":"1989","journal-title":"J Urol"},{"key":"R45-3-20240808","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/art.1780370206","article-title":"Nomenclature of systemic vasculitides: proposal of an international consensus conference.","volume":"37","author":"Jennette","year":"1994","journal-title":"Arthritis Rheum"},{"key":"R46-3-20240808","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.berh.2004.09.001","article-title":"Classification and diagnostic criteria in systemic vasculitis.","volume":"19","author":"Saleh","year":"2005","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"R47-3-20240808","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s00415-005-0833-9","article-title":"Primary and secondary vasculitic neuropathy.","volume":"252","author":"Said","year":"2005","journal-title":"J Neurol"},{"key":"R48-3-20240808","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1085-9489.2006.00060.x","article-title":"Combined nerve and muscle biopsy in the diagnosis of vasculitic neuropathy: a 16-year retrospective study of 202 cases.","volume":"11","author":"Vital","year":"2006","journal-title":"J Peripher Nerv Syst"},{"key":"R49-3-20240808","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/s12019-007-0012-2","article-title":"Polyarteritis nodosa.","volume":"33","author":"Pettigrew","year":"2007","journal-title":"Compr Ther"},{"key":"R50-3-20240808","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/00019052-200406000-00014","article-title":"Vasculitis of the nervous system.","volume":"17","author":"Younger","year":"2004","journal-title":"Curr Opin Neurol"},{"key":"R51-3-20240808","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/BF01951493","article-title":"Immunopathogenesis of the extrahepatic manifestations of hepatitis B virus infection.","volume":"3","author":"Dientag","year":"1981","journal-title":"Springer Semin Immunopathol"},{"key":"R52-3-20240808","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1006\/jaut.2000.0502","article-title":"Polyarteritis nodosa and extrahepatic manifestations of HBV infection: the case against autoimmune intervention in pathogenesis.","volume":"16","author":"Trepo","year":"2001","journal-title":"J Autoimmun"},{"key":"R53-3-20240808","first-page":"97","article-title":"Systemic vasculitis of the polyarteritis nodosa group and infection with hepatitis B virus: a study in 98 patients.","volume":"1","author":"Guillevin","year":"1989","journal-title":"Eur J Intern Med"},{"key":"R54-3-20240808","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0016-5085(80)90130-4","article-title":"Seroconversion from hepatitis B e antigen to anti-HBe in chronic hepatitis B virus infection.","volume":"79","author":"Realdi","year":"1980","journal-title":"Gastroenterology"},{"issue":"Suppl 1","key":"R55-3-20240808","first-page":"63","article-title":"Polyarteritis nodosa related to hepatitis B virus. A retrospective study of 66 patients.","volume":"143","author":"Guillevin","year":"1992","journal-title":"Ann Med Interne (Paris)"},{"key":"R56-3-20240808","first-page":"289","article-title":"Treatment of polyarteritis nodosa related to hepatitis B virus with short term steroid therapy associated with antiviral agents and plasma exchanges. A prospective trial in 33 patients.","volume":"20","author":"Guillevin","year":"1993","journal-title":"J Rheumatol"},{"key":"R57-3-20240808","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1136\/ard.53.5.334","article-title":"Treatment of polyarteritis nodosa related to hepatitis B virus with interferon-alpha and plasma exchanges.","volume":"53","author":"Guillevin","year":"1994","journal-title":"Ann Rheum Dis"},{"key":"R58-3-20240808","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/art.20401","article-title":"Short-term corticosteroids then lamivudine and plasma exchanges to treat hepatitis B virus-associated polyarteritis nodosa.","volume":"51","author":"Guillevin","year":"2004","journal-title":"Arthritis Rheumatol"},{"key":"R59-3-20240808","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1001\/archinte.1966.00290140043009","article-title":"The Guillain-Barre syndrome.","volume":"118","author":"Leneman","year":"1966","journal-title":"Arch Intern Med"},{"key":"R60-3-20240808","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1212\/WNL.51.4.1110","article-title":"The spectrum of antecedent infections in Guillain-Barre syndrome: a case-control study.","volume":"51","author":"Jacobs","year":"1998","journal-title":"Neurology"},{"key":"R61-3-20240808","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/jmv.1890210303","article-title":"Guillain-Barre syndrome and other neurologic syndromes in hepatitis A, B, and non-A, non-B.","volume":"21","author":"Tabor","year":"1987","journal-title":"J Med Virol"},{"key":"R62-3-20240808","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1001\/archneur.1981.00510060068011","article-title":"Guillain-Barre syndrome complicating acute hepatitis B. A case with detailed electrophysiological and immunological studies.","volume":"38","author":"Berger","year":"1980","journal-title":"Arch Neurol"},{"key":"R63-3-20240808","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1080\/13550280390201731","article-title":"A case of relapsing Guillain-Barre syndrome associated with exacerbation of chronic hepatitis B virus hepatitis.","volume":"9","author":"Chroni","year":"2003","journal-title":"J Neurovirol"},{"key":"R64-3-20240808","first-page":"161","article-title":"Association of Guillain-Barre syndrome and B-virus hepatitis: simultaneous presence of anti-ds-DNA antibodies and HBs antigen in cerebrospinal fluid.","volume":"11","author":"Feutren","year":"1983","journal-title":"J Clin Lab Immunol"},{"key":"R65-3-20240808","first-page":"652","article-title":"Chronic hepatitis B exacerbated by Guillain-Barre syndrome: a report of two cases.","volume":"62","author":"Han","year":"1999","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"R66-3-20240808","first-page":"1157","article-title":"Hepatitis B surface antigen in the cerebrospinal fluid in a case of Guillain-Barre syndrome.","volume":"122","author":"Huet","year":"1980","journal-title":"Can Med Assoc J"},{"key":"R67-3-20240808","first-page":"428","article-title":"Hepatitis B virus replication in the cerebrospinal fluid in Guillain-Barre syndrome.","volume":"20","author":"Jean","year":"1991","journal-title":"Presse Med"},{"key":"R68-3-20240808","first-page":"447","article-title":"Guillain-Barre syndrome associated to a type B acute hepatitis.","volume":"15","author":"Marti-Masso","year":"1979","journal-title":"Med Clin (Barc)"},{"key":"R69-3-20240808","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1445-5994.1975.tb03274.x","article-title":"Guillain Barre syndrome during the pre-icteric phase of acute type B viral hepatitis.","volume":"5","author":"Ng","year":"1975","journal-title":"Aust N Z J Med"},{"key":"R70-3-20240808","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1136\/bmj.4.5999.732-a","article-title":"Guillain Barre syndrome in acute HBsAg-positive hepatitis.","volume":"2","author":"Niermeijer","year":"1975","journal-title":"BMJ"},{"key":"R71-3-20240808","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/S0016-5085(82)80411-3","article-title":"Serum and cerebrospinal fluid immune complexes containing hepatitis B surface antigen in Guillain-Barre syndrome.","volume":"82","author":"Penner","year":"1982","journal-title":"Gastroenterology"},{"key":"R72-3-20240808","first-page":"146","article-title":"Guillain-Barre polyradiculitis in acute viral hepatitis type B: case report.","volume":"43","author":"Porst","year":"1983","journal-title":"Dtsch Z Verdau Stoffwechselkr"},{"key":"R73-3-20240808","first-page":"228","article-title":"Acute hepatitis B presenting as Guillain-Barre syndrome.","volume":"22","author":"Ray","year":"2003","journal-title":"Indian J Gastroenterol"},{"key":"R74-3-20240808","first-page":"548","article-title":"Peripheral neuropathy, first manifestation of hepatitis B virus infection.","volume":"24","author":"Saiz-Hervas","year":"1995","journal-title":"Presse Med"},{"key":"R75-3-20240808","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0022-510X(87)90123-7","article-title":"Demyelinating neuropathy associated with hepatitis B virus infection. Detection of immune complexes composed of hepatitis B virus surface antigen.","volume":"77","author":"Tsukada","year":"1987","journal-title":"J Neurol Sci"},{"key":"R76-3-20240808","first-page":"305","article-title":"Guillain-Barre syndrome and HBsAg-positive acute viral hepatitis.","volume":"28","author":"Walle","year":"1981","journal-title":"Hepatogastroenterology"},{"key":"R77-3-20240808","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/S0140-6736(75)91796-1","article-title":"HBsAg in spinal fluid from leukemic children.","volume":"1","author":"Dankert","year":"1975","journal-title":"Lancet"},{"key":"R78-3-20240808","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S0140-6736(75)80041-9","article-title":"HBsAg in spinal fluid in leukemia.","volume":"2","author":"Schiliro","year":"1975","journal-title":"Lancet"},{"key":"R79-3-20240808","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/mpo.2950080203","article-title":"Hepatitis B surface antigen in spinal fluid.","volume":"8","author":"Spiegel","year":"1980","journal-title":"Med Pediatr Oncol"},{"key":"R80-3-20240808","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1590\/S0036-46652002000300011","article-title":"Confluent peripheral multiple mononeuropathy associated to acute hepatitis B: a case report.","volume":"44","author":"Caniello","year":"2002","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"R81-3-20240808","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0022-510X(83)90005-9","article-title":"Chronic neuropathy associated with immune complexes of hepatitis B virus.","volume":"61","author":"Tsukada","year":"1983","journal-title":"J Neurol Sci"},{"key":"R82-3-20240808","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1212\/WNL.37.10.1663","article-title":"Chronic relapsing demyelinating polyneuropathy associated with hepatitis B infection.","volume":"37","author":"Inoue","year":"1987","journal-title":"Neurology"},{"key":"R83-3-20240808","first-page":"161","article-title":"Chronic inflammatory demyelinating polyneuropathy associated with chronic liver disease due to type B and type C hepatitis virus.","volume":"47","author":"Ohyama","year":"1995","journal-title":"No To Shinkei"},{"key":"R84-3-20240808","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/ana.410070402","article-title":"Disseminated vasculomyelinopathyan immune complex disease.","volume":"7","author":"Reik","year":"1980","journal-title":"Ann Neurol"},{"key":"R85-3-20240808","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/BF00690959","article-title":"Peripheral nerve tissue injury induced by galactocerebroside and galactocerebroside immune complexes.","volume":"66","author":"Tsukada","year":"1985","journal-title":"Acta Neuropath (Berlin)"},{"key":"R86-3-20240808","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s12016-007-8065-7","article-title":"The last classification of vasculitis.","volume":"35","author":"Kallenberg","year":"2008","journal-title":"Clin Rev Allergy Immunol"},{"key":"R87-3-20240808","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/mus.880130304","article-title":"Mononeuropathy multiplex associated with acute hepatitis B infection.","volume":"13","author":"Cohen","year":"1990","journal-title":"Muscle Nerve"},{"key":"R88-3-20240808","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/0091-6749(78)90211-7","article-title":"McIntosh RM. Small vessel vasculitis caused by hepatitis B virus immune complexes. Small vessel vasculitis and HBsAg.","volume":"62","author":"Gower","year":"1978","journal-title":"J Allergy Clin Immunol"},{"key":"R89-3-20240808","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1001\/archinte.1981.00340050075018","article-title":"Cutaneous vasculitis associated with acute and chronic hepatitis.","volume":"141","author":"Popp","year":"1981","journal-title":"Arch Intern Med"},{"key":"R90-3-20240808","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.clineuro.2008.05.006","article-title":"Hepatitis B virus-related vasculitis manifesting as severe peripheral neuropathy following influenza vaccination.","volume":"110","author":"Wada","year":"2008","journal-title":"Clin Neurol Neurosurg"},{"key":"R91-3-20240808","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1001\/archneur.1973.00490240070013","article-title":"Idiopathic inflammatory myopathy. Failure to detect hepatitis B antigen in serum and muscle.","volume":"28","author":"Whitaker","year":"1973","journal-title":"Arch Neurol"},{"key":"R92-3-20240808","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1212\/01.wnl.0000240078.47020.5e","article-title":"The association of chronic hepatitis B and myopathy.","volume":"67","author":"Capasso","year":"2006","journal-title":"Neurology"},{"key":"R93-3-20240808","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S0046-8177(80)80058-X","article-title":"Immune complex myositis associated with viral hepatitis.","volume":"11","author":"Damjanov","year":"1980","journal-title":"Hum Pathol"},{"key":"R94-3-20240808","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1001\/jama.1978.03280300053021","article-title":"Hepatitis B antigen and polymyositis.","volume":"239","author":"Mihas","year":"1978","journal-title":"JAMA"},{"key":"R95-3-20240808","doi-asserted-by":"crossref","first-page":"519","DOI":"10.2169\/internalmedicine.37.519","article-title":"Antibody to hepatitis B e positive hepatitis induced by withdrawal of steroid therapy for polymyositis: response to interferon-alpha and cyclosporine A.","volume":"37","author":"Nakanishi","year":"1998","journal-title":"Intern Med"},{"key":"R96-3-20240808","first-page":"86","article-title":"A case of polymyositis associated with hepatitis B infection.","volume":"18","author":"Nojima","year":"2000","journal-title":"Clin Exp Rheumatol"},{"key":"R97-3-20240808","first-page":"73","article-title":"Viral hepatitis B and polymyositis. Description of a case of polymyositis associated with viral hepatitis B.","volume":"80","author":"Pizzigallo","year":"1988","journal-title":"Pathologica"},{"key":"R98-3-20240808","first-page":"749","article-title":"Appearance of a polymyositis late in the development of hepatitis B.","volume":"39","author":"Reginster","year":"1984","journal-title":"Rev Med Liege"},{"key":"R99-3-20240808","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1046\/j.1440-1746.2002.t01-1-02851.x","article-title":"Dermatomyositis and erythrocytosis associated with hepatocellular carcinoma.","volume":"17","author":"Cheng","year":"2002","journal-title":"J Gastroenterol Hepatol"},{"key":"R100-3-20240808","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s00296-008-0718-1","article-title":"Dermatomyositis associated with hepatitis B virus-related hepatocellular carcinoma.","volume":"29","author":"Kee","year":"2009","journal-title":"Rheumatol Int"},{"key":"R101-3-20240808","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/(SICI)1096-9071(199711)53:3<266::AID-JMV15>3.0.CO;2-F","article-title":"Sequential analyses of the mutation in the core upstream and precore regions of hepatitis B virus genome in anti-HBe positive-carriers developing acute exacerbation.","volume":"53","author":"Nishizono","year":"1997","journal-title":"J Med Virol"},{"key":"R102-3-20240808","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1001\/jama.1978.03280370055026","article-title":"Acute hepatitis B simulating dermatomyositis.","volume":"239","author":"Pittsley","year":"1978","journal-title":"JAMA"},{"key":"R103-3-20240808","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/art.1780400232","article-title":"Dermatomyositis, hepatocarcinoma, and hepatitis C: comment on the article by Weidensaul et al.","volume":"40","author":"Gomez","year":"1997","journal-title":"Arthritis Rheum"},{"key":"R104-3-20240808","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1046\/j.1365-2133.2001.04040.x","article-title":"Acquired ichthyosis associated with dermatomyositis in a patient with hepatocellular carcinoma.","volume":"144","author":"Inuzuka","year":"2001","journal-title":"Br J Dermatol"},{"key":"R105-3-20240808","first-page":"834","article-title":"Chronic hepatitis C virus infection associated with dermatomyositis and hepatocellular carcinoma.","volume":"27","author":"Kee","year":"2004","journal-title":"Chang Gung Med J"},{"key":"R106-3-20240808","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.3748\/wjg.v12.i10.1641","article-title":"Dermatomyositis associated with hepatocellular carcinoma in an elderly female patient with hepatitis C virus-related liver cirrhosis.","volume":"12","author":"Toshikuni","year":"2006","journal-title":"World J Gastroenterol"},{"key":"R107-3-20240808","first-page":"227","article-title":"Aberrant serum enzyme patterns in dermatomyositis associated with hepatoma.","volume":"3","author":"Gray","year":"1976","journal-title":"J Rheumatol"},{"key":"R108-3-20240808","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1440-1746.1989.tb00812.x","article-title":"Combined hepatocellular-cholangiocarcinoma associated with dermatomyositis.","volume":"4","author":"Horie","year":"1989","journal-title":"J Gastroenterol Hepatol"},{"key":"R109-3-20240808","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0140-6736(00)03540-6","article-title":"Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study.","volume":"357","author":"Hill","year":"2001","journal-title":"Lancet"},{"key":"R110-3-20240808","first-page":"1855","article-title":"The overall and temporal association of cancer with polymyositis and dermatomyositis.","volume":"21","author":"Zantos","year":"1994","journal-title":"J Rheumatol"},{"key":"R111-3-20240808","first-page":"101","article-title":"Dermatomyositis sine myositis: association with malignancy.","volume":"23","author":"Whitmore","year":"1996","journal-title":"J Rheumatol"},{"key":"R112-3-20240808","doi-asserted-by":"crossref","first-page":"417","DOI":"10.7326\/0003-4819-87-4-417","article-title":"Hepatitis-associated lipid storage myopathy.","volume":"87","author":"Patten","year":"1977","journal-title":"Ann Intern Med"},{"key":"R113-3-20240808","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1001\/jama.1980.03300410014012","article-title":"Hepatitis B antigen associated with cryoglobulinemia, peripheral neuropathy, and myopathy.","volume":"243","author":"Flatau","year":"1980","journal-title":"JAMA"}],"container-title":["Journal of Clinical Neuromuscular Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00131402-201109000-00003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T23:15:01Z","timestamp":1723158901000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00131402-201109000-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":111,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/cnd.0b013e3181df2b2b","relation":{},"ISSN":["1522-0443"],"issn-type":[{"value":"1522-0443","type":"print"}],"subject":[],"published":{"date-parts":[[2011,9]]}}}